S'abonner

Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance - 03/02/12

Doi : 10.1016/j.jaci.2011.09.031 
Oscar Palomares, PhD a, , Beate Rückert a, Tuomas Jartti, MD b, Umut Can Kücüksezer, MD, PhD a, d, Tuomo Puhakka, MD c, e, Enrique Gomez, PhD a, Heinz B. Fahrner, MD f, Andreas Speiser, MD g, Andreas Jung, MD a, h, William W. Kwok, PhD i, Livije Kalogjera, MD j, Mübeccel Akdis, MD, PhD a, Cezmi A. Akdis, MD a,
a Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland 
b Department of Pediatrics, Turku University Hospital, Turku, Finland 
c Department of Otorhinolaryngology, Turku University Hospital, Turku, Finland 
d Department of Immunology, Institute for Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey 
e Department of Otorhinolaryngology, Satakunta Central Hospital, Pori, Finland 
f Department of ENT, Kantonsspital Graubünden, Chur, Switzerland 
g Spital Davos, Davos, Switzerland 
h Hochgebirgsklinik, Davos, Switzerland 
i Benaroya Research Institute at Virginia Mason, Seattle, Wash 
j Department of ORL, Zagreb School of Medicine, University Hospital Centre “Sestre Milosrdnice,” Zagreb, Croatia 

Corresponding authors: Cezmi A. Akdis, MD, and Oscar Palomares, PhD, Swiss Institute of Allergy and Asthma Research (SIAF), Obere Str. 22, CH-7270, Davos Platz, Switzerland.

Abstract

Background

Tonsils are strategically located in the gateway of both alimentary and respiratory tracts representing the first contact point of food and aeroallergens with the immune system. Tonsillectomy removes only the palatine tonsils and sometimes adenoids. Lingual tonsil is anatomically big and remains lifelong intact.

Objective

The aim of this study was to demonstrate cellular and molecular mechanisms of oral tolerance induction to food and aeroallergens in human tonsils.

Methods

Tonsil allergen-specific FOXP3+ regulatory T (Treg) cells, plasmacytoid dendritic cells (pDCs), and myeloid dendritic cells were characterized by flow cytometry and suppressive assays. Intracellular staining, [3H]-thymidine incorporation, and carboxy-fluorescein succinimidyl ester dilution experiments were performed. Tonsil biopsies were analyzed by confocal microscopy.

Results

CD4+FOXP3+ Treg cells and pDCs constitute important T- and dendritic cell–compartments in palatine and lingual tonsils. Tonsil pDCs have the ability to generate functional CD4+CD25+CD127FOXP3+ Treg cells with suppressive property from naive T cells. CD4+FOXP3+ Treg cells proliferate and colocalize with pDCs in vivo in T-cell areas of lingual and palatine tonsils. Tonsil T cells did not proliferate to common food and aeroallergens. Depletion of FOXP3+ Treg cells enables the allergen-induced proliferation of tonsil T cells, indicating an active role of Treg cells in allergen-specific T-cell unresponsiveness. High numbers of major birch pollen allergen, Bet v 1–specific CD4+FOXP3+ Treg cells, are identified in human tonsils compared with peripheral blood. A positive correlation between the percentages of FOXP3+ Treg cells and pDCs is observed in tonsils from nonatopic individuals.

Conclusion

Functional allergen-specific Treg cells are identified both in lingual and in palatine tonsils.

Le texte complet de cet article est disponible en PDF.

Key words : Immune tolerance, tonsils, allergen-specific Treg cells, plasmacytoid dendritic cells, myeloid dendritic cells

Abbreviations used : CFSE, DCs, mDCs, PC5, pDCs, TDCs, TLR, TMCs, Treg


Plan


 The authors’ laboratories are supported by Swiss National Foundation grants 32-125249 and 320030-132899 and Christine Kühne-Center for Allergy Research and Education (CK-CARE). O.P. was supported by a postdoctoral fellowship from Ministerio de Educación y Ciencia and FECYT (Spain) and W.W.K by NIH contract HHSN272200700046C.
 This work was supported by the European Commission’s Seventh Framework Programme under grant agreement no. 261357.
 Disclosure of potential conflict of interest: M. Akdis has received research support from the Swiss National Foundation, European Commission FP7 (MeDALL), and Predicta. C. A. Akdis has received research support from Novartis, Stallergenes, the Swiss National Science Foundation, Global Allergy and Asthma European Network, and Christine Kühne-Center for Allergy Research and Education; is a Fellow and interest group member of the American Academy of Allergy, Asthma & Immunology; is Vice President of the European Academy of Allergy and Clinical Immunology; and was a committee member for GA2LEN. The rest of the authors declare that they have no relevant conflicts of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129 - N° 2

P. 510 - février 2012 Retour au numéro
Article précédent Article précédent
  • Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain
  • Eszter Herczenik, Simon D. van Haren, Aleksandra Wroblewska, Paul Kaijen, Maartje van den Biggelaar, Alexander B. Meijer, Luisa Martinez-Pomares, Anja ten Brinke, Jan Voorberg
| Article suivant Article suivant
  • CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease
  • Helen Martin, Sebastian Reuter, Nina Dehzad, Anke Heinz, Iris Bellinghausen, Joachim Saloga, Ina Haasler, Stephanie Korn, Helmut Jonuleit, Roland Buhl, Christian Becker, Christian Taube

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.